Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zanfina Ademi

Showing results (1-10 of 227) with videos related to

Pageof 23
Sort By:
Applied Health Economics and Health Policy|October 5, 2016
Clinical and Cost Effectiveness of Apixaban Compared to Aspirin in Patients with Atrial Fibrillation: An Australian PerspectiveZanfina Ademi, Kumar Pasupathi, Danny Liew
European Journal of Preventive Cardiology|November 28, 2013
Cost-effectiveness of apixaban compared to warfarin in the management of atrial fibrillation in AustraliaZanfina Ademi, Kumar Pasupathi, Danny Liew
Medicine|May 6, 2016
Cost-Effectiveness of Eplerenone Compared to Usual Care in Patients With Chronic Heart Failure and NYHA Class II Symptoms, an Australian PerspectiveZanfina Ademi, Kumar Pasupathi, Danny Liew
Current Opinion in Endocrinology, Diabetes, and Obesity|February 12, 2025
Perspectives on early health economic evaluations of RNA therapies targeted at lipoprotein(a)Angela Burvill, Gerald F Watts, Zanfina Ademi
Arthritis Care & Research|March 29, 2022
Loss of Productivity-Adjusted Life-Years in Working-Age Australians Due to Knee Osteoarthritis: A Life-Table Modeling ApproachXingzhong Jin, Ilana N Ackerman, Zanfina Ademi
Current Opinion in Endocrinology, Diabetes, and Obesity|November 20, 2023
Health economics of detection and treatment of children with familial hypercholesterolemia: to screen or not to screen is no longer the questionClara Marquina, Jedidiah I Morton, Zanfina Ademi
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 2, 2024
A Causal Model for Primary Prevention of Cardiovascular Disease: The Health Economic Model for the Primary Prevention of Cardiovascular DiseaseJedidiah I Morton, Danny Liew, Zanfina Ademi
Applied Health Economics and Health Policy|June 25, 2021
The Health and Productivity Burden of Depression in South KoreaElla Zomer, YongJoo Rhee, Danny Liew, et al.
Cancer Epidemiology|December 11, 2024
The productivity burden of breast cancer in AustraliaMelanie Lloyd, Divya Bassi, Ella Zomer, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|March 11, 2014
Cost effectiveness of eplerenone in patients with chronic heart failureZanfina Ademi, Kumar Pasupathi, Henry Krum, et al.
Pageof 23

Showing results (1-10 of 227) with videos related to

Sort By:
Pageof 23
Applied Health Economics and Health Policy|October 5, 2016
Clinical and Cost Effectiveness of Apixaban Compared to Aspirin in Patients with Atrial Fibrillation: An Australian PerspectiveZanfina Ademi, Kumar Pasupathi, Danny Liew
European Journal of Preventive Cardiology|November 28, 2013
Cost-effectiveness of apixaban compared to warfarin in the management of atrial fibrillation in AustraliaZanfina Ademi, Kumar Pasupathi, Danny Liew
Medicine|May 6, 2016
Cost-Effectiveness of Eplerenone Compared to Usual Care in Patients With Chronic Heart Failure and NYHA Class II Symptoms, an Australian PerspectiveZanfina Ademi, Kumar Pasupathi, Danny Liew
Current Opinion in Endocrinology, Diabetes, and Obesity|February 12, 2025
Perspectives on early health economic evaluations of RNA therapies targeted at lipoprotein(a)Angela Burvill, Gerald F Watts, Zanfina Ademi
Arthritis Care & Research|March 29, 2022
Loss of Productivity-Adjusted Life-Years in Working-Age Australians Due to Knee Osteoarthritis: A Life-Table Modeling ApproachXingzhong Jin, Ilana N Ackerman, Zanfina Ademi
Current Opinion in Endocrinology, Diabetes, and Obesity|November 20, 2023
Health economics of detection and treatment of children with familial hypercholesterolemia: to screen or not to screen is no longer the questionClara Marquina, Jedidiah I Morton, Zanfina Ademi
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 2, 2024
A Causal Model for Primary Prevention of Cardiovascular Disease: The Health Economic Model for the Primary Prevention of Cardiovascular DiseaseJedidiah I Morton, Danny Liew, Zanfina Ademi
Applied Health Economics and Health Policy|June 25, 2021
The Health and Productivity Burden of Depression in South KoreaElla Zomer, YongJoo Rhee, Danny Liew, et al.
Cancer Epidemiology|December 11, 2024
The productivity burden of breast cancer in AustraliaMelanie Lloyd, Divya Bassi, Ella Zomer, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|March 11, 2014
Cost effectiveness of eplerenone in patients with chronic heart failureZanfina Ademi, Kumar Pasupathi, Henry Krum, et al.
Pageof 23